Anti-STAT3 monoclonal antibody

Pre-made anti-STAT3 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to STAT3/STAT3 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T29130-Ab-1/ GM-Tg-hg-T29130-Ab-2Anti-Human STAT3 monoclonal antibodyHuman
GM-Tg-rg-T29130-Ab-1/ GM-Tg-rg-T29130-Ab-2Anti-Rat STAT3 monoclonal antibodyRat
GM-Tg-mg-T29130-Ab-1/ GM-Tg-mg-T29130-Ab-2Anti-Mouse STAT3 monoclonal antibodyMouse
GM-Tg-cynog-T29130-Ab-1/ GM-Tg-cynog-T29130-Ab-2Anti-Cynomolgus/ Rhesus macaque STAT3 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T29130-Ab-1/ GM-Tg-felg-T29130-Ab-2Anti-Feline STAT3 monoclonal antibodyFeline
GM-Tg-cang-T29130-Ab-1/ GM-Tg-cang-T29130-Ab-2Anti-Canine STAT3 monoclonal antibodyCanine
GM-Tg-bovg-T29130-Ab-1/ GM-Tg-bovg-T29130-Ab-2Anti-Bovine STAT3 monoclonal antibodyBovine
GM-Tg-equg-T29130-Ab-1/ GM-Tg-equg-T29130-Ab-2Anti-Equine STAT3 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T29130-Ab-1/ GM-Tg-hg-T29130-Ab-2; GM-Tg-rg-T29130-Ab-1/ GM-Tg-rg-T29130-Ab-2;
GM-Tg-mg-T29130-Ab-1/ GM-Tg-mg-T29130-Ab-2; GM-Tg-cynog-T29130-Ab-1/ GM-Tg-cynog-T29130-Ab-2;
GM-Tg-felg-T29130-Ab-1/ GM-Tg-felg-T29130-Ab-2; GM-Tg-cang-T29130-Ab-1/ GM-Tg-cang-T29130-Ab-2;
GM-Tg-bovg-T29130-Ab-1/ GM-Tg-bovg-T29130-Ab-2; GM-Tg-equg-T29130-Ab-1/ GM-Tg-equg-T29130-Ab-2
Products NameAnti-STAT3 monoclonal antibody
Formatmab
Target NameSTAT3
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-STAT3 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T29130-Ag-1Recombinant multi-species STAT3/ ADMIO/ ADMIO1 protein
    ORF Viral VectorvGMAD000377human STAT3 Adenovirus particle
    ORF Viral VectorpGMLV000031human STAT3 Lentivirus plasmid
    ORF Viral VectorpGMLV000030human STAT3 Lentivirus plasmid
    ORF Viral VectorvGMLV000031human STAT3 Lentivirus particle
    ORF Viral VectorvGMLV000030human STAT3 Lentivirus particle
    ORF Viral VectorpGMAD000377human STAT3 Adenovirus plasmid
    ORF Viral VectorpGMLV000818house mouse Stat3 Lentivirus plasmid
    ORF Viral VectorpGMAD000253rat Stat3 Adenovirus plasmid
    ORF Viral VectorpGMAD000541Norway rat Stat3 Adenovirus plasmid
    ORF Viral VectorpGMAAV000145mouse Stat3 AAV plasmid
    ORF Viral VectorvGMLV000818house mouse Stat3 Lentivirus particle
    ORF Viral VectorvGMAD000253rat Stat3 Adenovirus particle
    ORF Viral VectorvGMAD000541Norway rat Stat3 Adenovirus particle
    ORF Viral VectorvGMAAV000145mouse Stat3 AAV particle


    Target information

    Target IDGM-T29130
    Target NameSTAT3
    Gene ID6774,20848,25125,574128,490967,101095698,508541,100034011
    Gene Symbol and Synonyms1110034C02Rik,ADMIO,ADMIO1,APRF,HIES,STAT3
    Uniprot AccessionP40763,P52631,P61635
    Uniprot Entry NameSTAT3_HUMAN,STAT3_RAT,STAT3_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Immuno-oncology Target
    DiseaseCancer
    Gene EnsemblENSG00000168610
    Target ClassificationCheckpoint-Immuno Oncology, Tumor-associated antigen (TAA)

    The target: STAT3, gene name: STAT3, also named as ADMIO, ADMIO1, APRF, HIES. The protein encoded by this gene is a member of the STAT protein family. In response to cytokines and growth factors, STAT family members are phosphorylated by the receptor associated kinases, and then form homo- or heterodimers that translocate to the cell nucleus where they act as transcription activators. This protein is activated through phosphorylation in response to various cytokines and growth factors including IFNs, EGF, IL5, IL6, HGF, LIF and BMP2. This protein mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis. The small GTPase Rac1 has been shown to bind and regulate the activity of this protein. PIAS3 protein is a specific inhibitor of this protein. This gene also plays a role in regulating host response to viral and bacterial infections. Mutations in this gene are associated with infantile-onset multisystem autoimmune disease and hyper-immunoglobulin E syndrome. [provided by RefSeq, Aug 2020].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.